“…Possible networks of protein or gene interactions with KCNN3 included 49 gene or gene products associated with drug-resistance in OC, which further explained its association with drug resistance. These genes/gene products included 25 oncogenes ( 35 ); URI1, STAT3, SRC, RSF1, PIK3CA, NOTCH3, NINL, NFKB1, MYC, MIEN1, MET, KRAS, JUN, IKBKE, FOS, ERBB2, EGFR, DAXX, CUZD1, CLU, BCL2, BAX, AKT2, AKT1 and ACTN4 and 15 tumor suppressors ( 36 ) including BRCA1, BRCA2, CHEK2, FBXO32, MLH1, SULF1, IL24, CDKN2A, CDKN1A, TP53, TP73, PDCD4, PTEN, RASSF1 and WWOX, as well as 9 other genes, including CCL21 and SPARCL1 ( 37 ), GGNBP2 and RNASET2 ( 38 ), NEK2 ( 39 ), NEK11 ( 40 ), ALDH1A2 and ADH1B ( 41 ) and TRPC1 ( 42 ). KCNN3 directly interacted with 18 of these genes or gene products, and exhibited indirect interactions with the rest ( Fig.…”